CIK 0001503802
- Non-accelerated filer
- Smaller reporting company
Karyopharm Therapeutics Inc.
Sign in to watch- Tickers
- KPTI KPTIQ
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 263931704
- Phone
- +1 617-658-0600
- Business address
- 85 WELLS AVENUE, SECOND FLOOR, NEWTON, MA, 02459
Securities
- KPTI Common stock Nasdaq
- KPTIQ Common stock OTC
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy EVP, Chief Medical Officer bought 23,250 shares at $8.60 ($199,992)
- 4 Open-market buy Director bought 4,000 shares at $7.82 ($31,280)
- 4 Grant or award President and CEO acquired 373,200 shares (grant or award)
- 4 Open-market sale President & CSO sold 4,000 shares at $12.39 ($49,553)
- 4 Open-market sale Chief Executive Officer sold 4,000 shares at $12.39 ($49,553)
- 4 Grant or award EVP, Chief Medical Officer acquired 22,013 shares (grant or award)
- 4 Grant or award SVP, CFO & Treasurer acquired 22,013 shares (grant or award)
- 4 Grant or award EVP, Chief Reg. Affairs acquired 22,013 shares (grant or award)
- 4 Grant or award EVP, Chief Dev. Officer acquired 22,013 shares (grant or award)
- 4 Grant or award Chief Commercial Officer acquired 15,849 shares (grant or award)
- 4 Grant or award President & CSO acquired 114,400 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 114,400 shares (grant or award)
- 4 Open-market sale EVP, Chief Medical Officer sold 1,186 shares at $14.83 ($17,590)
- 4 Open-market sale EVP, Chief Dev. Officer sold 2,887 shares at $14.83 ($42,818)
- 4 Open-market sale President & CSO sold 18,990 shares at $14.83 ($281,644)
- 4 Open-market sale Chief Executive Officer sold 18,990 shares at $14.83 ($281,644)
- 4 Open-market sale EVP, Chief Reg. Affairs sold 2,046 shares at $15.52 ($31,752)
Page 12 of 31 · 601 filings